JW Pharmaceutical Overview

  • Founded
  • 1945
Founded
  • Status
  • Public
  • Employees
  • 1,146
Employees
  • Stock Symbol
  • 001060
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $16.85
  • (As of Friday Closing)

JW Pharmaceutical General Information

Description

JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
KRX
Primary Office
  • 2477, Nambusunhwan-ro Seocho-gu
  • Seoul, 137-864
  • South Korea
+82 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

JW Pharmaceutical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$16.85 $17.04 $16.37 - $29.34 $369M 21.9M 68.2K -$0.06

JW Pharmaceutical Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 577,357 783,228 641,408 844,738
Revenue 515,228 463,570 438,510 488,742
EBITDA 29,327 12,231 (2,432) 33,295
Net Income (1,054) (12,909) (21,675) 7,330
Total Assets 497,138 503,323 494,849 530,974
Total Debt 179,761 167,034 161,892 156,683
Public Fundamental Data provided by Morningstar, Inc. disclaimer

JW Pharmaceutical Patents

JW Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018325148-A1 Solid preparation comprising dutasteride and method for preparing same Pending 01-Sep-2017 0000000000
EP-3677253-A1 Solid preparation comprising dutasteride and method for preparing same Pending 01-Sep-2017 0000000000
EP-3677253-A4 Solid preparation comprising dutasteride and method for preparing same Pending 01-Sep-2017 0000000000 0
JP-2020532544-A Solid preparation containing dutasteride and its manufacturing method Pending 01-Sep-2017 0000000000
US-20200215081-A1 Solid preparation comprising dutasteride and method for preparing same Pending 01-Sep-2017 A61K9/2072
To view JW Pharmaceutical’s complete patent history, request access »

JW Pharmaceutical Executive Team (2)

Name Title Board Seat Contact Info
Shin Yeong-seop Chief Executive Officer
Chan-Hee Park Ph.D Executive
To view JW Pharmaceutical’s complete executive team members history, request access »

JW Pharmaceutical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

JW Pharmaceutical Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 000 04-Sep-2020 0000000000 Pharmaceuticals 0000 0000
Argonaut Therapeutics 19-Sep-2018 Later Stage VC 00.000 Drug Discovery 0000-000
To view JW Pharmaceutical’s complete investments and acquisitions history, request access »

JW Pharmaceutical Subsidiaries (1)

Company Name Industry Location Founded
000000000 00000000 Pharmaceuticals Duc Hoa District, Vietnam 0000
To view JW Pharmaceutical’s complete subsidiaries history, request access »